387 related articles for article (PubMed ID: 20832727)
1. Loss of miR-200 inhibition of Suz12 leads to polycomb-mediated repression required for the formation and maintenance of cancer stem cells.
Iliopoulos D; Lindahl-Allen M; Polytarchou C; Hirsch HA; Tsichlis PN; Struhl K
Mol Cell; 2010 Sep; 39(5):761-72. PubMed ID: 20832727
[TBL] [Abstract][Full Text] [Related]
2. MiR-137 Suppresses Triple-Negative Breast Cancer Stemness and Tumorigenesis by Perturbing BCL11A-DNMT1 Interaction.
Chen F; Luo N; Hu Y; Li X; Zhang K
Cell Physiol Biochem; 2018; 47(5):2147-2158. PubMed ID: 29975921
[TBL] [Abstract][Full Text] [Related]
3. Histone deacetylase 1/Sp1/microRNA-200b signaling accounts for maintenance of cancer stem-like cells in human lung adenocarcinoma.
Chen DQ; Huang JY; Feng B; Pan BZ; De W; Wang R; Chen LB
PLoS One; 2014; 9(10):e109578. PubMed ID: 25279705
[TBL] [Abstract][Full Text] [Related]
4. An integrated transcriptional regulatory circuit that reinforces the breast cancer stem cell state.
Polytarchou C; Iliopoulos D; Struhl K
Proc Natl Acad Sci U S A; 2012 Sep; 109(36):14470-5. PubMed ID: 22908280
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-128 coordinately targets Polycomb Repressor Complexes in glioma stem cells.
Peruzzi P; Bronisz A; Nowicki MO; Wang Y; Ogawa D; Price R; Nakano I; Kwon CH; Hayes J; Lawler SE; Ostrowski MC; Chiocca EA; Godlewski J
Neuro Oncol; 2013 Sep; 15(9):1212-24. PubMed ID: 23733246
[TBL] [Abstract][Full Text] [Related]
6. Direct targeting of SUZ12/ROCK2 by miR-200b/c inhibits cholangiocarcinoma tumourigenesis and metastasis.
Peng F; Jiang J; Yu Y; Tian R; Guo X; Li X; Shen M; Xu M; Zhu F; Shi C; Hu J; Wang M; Qin R
Br J Cancer; 2013 Dec; 109(12):3092-104. PubMed ID: 24169343
[TBL] [Abstract][Full Text] [Related]
7. FOXC1, a target of polycomb, inhibits metastasis of breast cancer cells.
Du J; Li L; Ou Z; Kong C; Zhang Y; Dong Z; Zhu S; Jiang H; Shao Z; Huang B; Lu J
Breast Cancer Res Treat; 2012 Jan; 131(1):65-73. PubMed ID: 21465172
[TBL] [Abstract][Full Text] [Related]
8. The polycomb repressive complex 2 is a potential target of SUMO modifications.
Riising EM; Boggio R; Chiocca S; Helin K; Pasini D
PLoS One; 2008 Jul; 3(7):e2704. PubMed ID: 18628979
[TBL] [Abstract][Full Text] [Related]
9. Role of p38γ MAPK in regulation of EMT and cancer stem cells.
Xu M; Wang S; Wang Y; Wu H; Frank JA; Zhang Z; Luo J
Biochim Biophys Acta Mol Basis Dis; 2018 Nov; 1864(11):3605-3617. PubMed ID: 30251680
[TBL] [Abstract][Full Text] [Related]
10. Cigarette smoke mediates epigenetic repression of miR-487b during pulmonary carcinogenesis.
Xi S; Xu H; Shan J; Tao Y; Hong JA; Inchauste S; Zhang M; Kunst TF; Mercedes L; Schrump DS
J Clin Invest; 2013 Mar; 123(3):1241-61. PubMed ID: 23426183
[TBL] [Abstract][Full Text] [Related]
11. Loss of miR-200b promotes invasion via activating the Kindlin-2/integrin β1/AKT pathway in esophageal squamous cell carcinoma: An E-cadherin-independent mechanism.
Zhang HF; Alshareef A; Wu C; Li S; Jiao JW; Cao HH; Lai R; Xu LY; Li EM
Oncotarget; 2015 Oct; 6(30):28949-60. PubMed ID: 26334393
[TBL] [Abstract][Full Text] [Related]
12. Polycomb complex 2 is required for E-cadherin repression by the Snail1 transcription factor.
Herranz N; Pasini D; Díaz VM; Francí C; Gutierrez A; Dave N; Escrivà M; Hernandez-Muñoz I; Di Croce L; Helin K; García de Herreros A; Peiró S
Mol Cell Biol; 2008 Aug; 28(15):4772-81. PubMed ID: 18519590
[TBL] [Abstract][Full Text] [Related]
13. MiR-200 can repress breast cancer metastasis through ZEB1-independent but moesin-dependent pathways.
Li X; Roslan S; Johnstone CN; Wright JA; Bracken CP; Anderson M; Bert AG; Selth LA; Anderson RL; Goodall GJ; Gregory PA; Khew-Goodall Y
Oncogene; 2014 Jul; 33(31):4077-88. PubMed ID: 24037528
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-200c attenuates tumour growth and metastasis of presumptive head and neck squamous cell carcinoma stem cells.
Lo WL; Yu CC; Chiou GY; Chen YW; Huang PI; Chien CS; Tseng LM; Chu PY; Lu KH; Chang KW; Kao SY; Chiou SH
J Pathol; 2011 Mar; 223(4):482-95. PubMed ID: 21294122
[TBL] [Abstract][Full Text] [Related]
15. Inducible formation of breast cancer stem cells and their dynamic equilibrium with non-stem cancer cells via IL6 secretion.
Iliopoulos D; Hirsch HA; Wang G; Struhl K
Proc Natl Acad Sci U S A; 2011 Jan; 108(4):1397-402. PubMed ID: 21220315
[TBL] [Abstract][Full Text] [Related]
16. miR-367 as a therapeutic target in stem-like cells from embryonal central nervous system tumors.
Kaid C; Jordan D; Bueno HMS; Araujo BHS; Assoni A; Okamoto OK
Mol Oncol; 2019 Dec; 13(12):2574-2587. PubMed ID: 31402560
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-125b transforms myeloid cell lines by repressing multiple mRNA.
Bousquet M; Nguyen D; Chen C; Shields L; Lodish HF
Haematologica; 2012 Nov; 97(11):1713-21. PubMed ID: 22689670
[TBL] [Abstract][Full Text] [Related]
18. E-cadherin transcriptional down-regulation by epigenetic and microRNA-200 family alterations is related to mesenchymal and drug-resistant phenotypes in human breast cancer cells.
Tryndyak VP; Beland FA; Pogribny IP
Int J Cancer; 2010 Jun; 126(11):2575-83. PubMed ID: 19839049
[TBL] [Abstract][Full Text] [Related]
19. Downregulation of miRNA-200c links breast cancer stem cells with normal stem cells.
Shimono Y; Zabala M; Cho RW; Lobo N; Dalerba P; Qian D; Diehn M; Liu H; Panula SP; Chiao E; Dirbas FM; Somlo G; Pera RA; Lao K; Clarke MF
Cell; 2009 Aug; 138(3):592-603. PubMed ID: 19665978
[TBL] [Abstract][Full Text] [Related]
20. miR-150 promotes human breast cancer growth and malignant behavior by targeting the pro-apoptotic purinergic P2X7 receptor.
Huang S; Chen Y; Wu W; Ouyang N; Chen J; Li H; Liu X; Su F; Lin L; Yao Y
PLoS One; 2013; 8(12):e80707. PubMed ID: 24312495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
